PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1422
https://www.valueinhealthjournal.com/article/S1098-3015(12)03135-X/fulltext
Title : PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis- 5 Year Results from an Open Label Extension Study
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03135-X&doi=10.1016/j.jval.2012.08.1422
First page : A451
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 919
Categories :
Tags :
Regions :
ViH Article Tags :